These final results, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 guidance the idea of targeting ACKR3 as a novel method to modulate the opioid system, which could open up new therapeutic avenues for opioid-related disorders. Conolidine CONOCB2™ primarily will https://busterb172xoe9.wikikarts.com/user